FindTrial
Sign In

The minimum effect-site concentration of propofol that is able to prevent the responses to stimuli used to evoke cranial reflexes - ND

The minimum effect-site concentration of propofol that is able to prevent the responses to stimuli used to evoke cranial reflexes - ND

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-001037-98-IT
Enrollment
Unknown
Registered
2008-06-12
Start date
2008-03-10
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients undergoing general anaesthesia for elective surgery

Interventions

Trade Name: DIPRIVAN Pharmaceutical Form: Emulsion for infusion INN or Proposed INN: Propofol Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 10-

Sponsors

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - age 18 years and older - general anaesthesia for elective surgery - ASA (American Society of Anaesthesiologists) I-II, - BMI (Body Mass Index)=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: - maxillo-facial surgery

Design outcomes

Primary

MeasureTime frame
Main Objective: The primary aim of the study is to determine the effect-site concentration of propofol that is able to prevent the responses to stimuli used to evoke cranial reflexes.;Secondary Objective: nd;Primary end point(s): nd—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026